ARTICLE | Clinical News
Calgene regulatory update
December 4, 1995 8:00 AM UTC
CGNE received a request for additional information as part of the Justice Department's antitrust review under the Hart-Scott-Rodino Act of its planned deal with Monsanto, under which the St. Louis company would acquire 49.9 percent of CGNE (see BioCentury Extra, June 29, 1995). ...